FDA Clears Caretaker Medical’s Wireless Platform for Continuous Noninvasive Blood Pressure and Hemodynamic Monitoring
The VitalStream wireless platform expands the company’s clinically validated PDA™ waveform analysis technology and AI algorithms.
Central Virginia to fast-track development of advanced pharmaceutical manufacturing with launch of 'cluster accelerator'
The regional cluster accelerator’s goal is to help build a globally competitive pharmaceutical manufacturing and R&D industry in the Central Virginia region.
Adial Pharmaceuticals Announces Research Collaboration Agreement with the University of Virginia to Advance Next Generation Adenosine Compounds for Wound Healing
Collaboration targeting development of new adenosine formulations that can be absorbed transdermally.
Susan Klees, HemoShear vice president of communications, has been appointed by Governor Ralph Northam to the Virginia Rare Disease Council.
Co-Founder and COO/CSO Amrie Grammer, Ph.D. will present at the annual BioHealth Capital Region (BHCR) Forum to introduce LuGENE®, a CLIA-certified blood test for disease assessment.
Virginia Bio to partner with Mason Enterprise to expand mentorship support for bio startups across the state
The new team of mentors will support a broad range of life science companies in bringing their innovations, including therapeutics, medical devices, diagnostics and software, to market.
Bonumose is pleased to announce the issuance of U.S. Patent No. 11,078,506 for “Enzymatic Production of D-Allulose”.
CvilleBioHub Announces Leadership Transition as the Biotechnology Innovation Cluster Experiences Strong Growth in Central Virginia
A new Executive Director and expanded entrepreneurship program will accelerate progress for new companies.
HemoShear Therapeutics, Inc. has announced that the first two patients have been dosed in Phase 2 clinical trial of HST5040.